Elekta Holds First Meeting of the MOSAIQ RTP Particle Therapy Global Council | Elekta Group
LinkedIn Login

Connect healthcare products, companies and hospitals with your LinkedIn network.

Facebook Login

Interact with your Facebook network around healthcare products, companies and hospitals.

Login With Facebook
MedicExchange Login

Enjoy Premium Access as a MedicExchange Member.

       Enter Your Email Address to Receive a
Copy of MedicExhange Member Demograhpics

Facebook Twitter Linkedin
Facebook: MedicExchange
Twitter: MedicExchange
Healthcare Company News Elekta Group Elekta Holds First Meeting of the MOSAIQ RTP Particle Therapy Global Council

Elekta Holds First Meeting of the MOSAIQ RTP Particle Therapy Global Council

Company News - Elekta Group
Elekta, a human care company pioneering significant innovations and clinical solutions for treating cancer and neurological conditions, announces the successful conclusion of the 1st meeting of the MOSAIQ Radiation Treatment Planning (RTP) Particle Therapy Global Council. Set within the wonderful Scenery of Courmayeur in the Italian Alps, the goal and achievement of the meeting was to develop robust planning tools in all Particle Therapy environments including Protons and Carbon ions within the MOSAIQ RTP framework. A collaborative discussion placed strong emphasis on Workflow Optimization and Integration with the EMR and how to improve Outcome Analysis and Evidence Based Medicine in Particle Therapy.

The council included representatives from industry leaders in the Particle Therapy field including Elekta and IBA, as well as innovators from ProCure, Trento, Oklahoma, NIRS-Japan and the University of Tuebingen. Participation from additional Particle Therapy leading centers is expected for the next Council meeting to be held during the 48th PTCOG in Heidelberg, Germany, September 2009.

The support of IBA Particle Therapy was greatly appreciated by members of the Elekta Group including Elekta Oncology, Impac Software, and CMS Software. The success of the meeting confirms the leadership of the two companies in the continuous development of a common strategy in the Particle Therapy field.

About Elekta

Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated state of the art tools and treatment planning systems for radiation therapy and radiosurgery, as well as workflow enhancing software systems across the spectrum of cancer care. For More information about Elekta,please visit www.elekta.com.

About IBA

IBA develops and markets leading edge technologies, pharmaceuticals and tailor-made solutions for healthcare with a focus on cancer diagnosis and therapy. Leveraging on its scientific expertise, IBA is also active in the field of industrial sterilization and ionization. Listed on the pan-European stock exchange EURONEXT, IBA is included in the BelMid Index. (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB). Website: www.iba-worldwide.com

Source: Elekta